SkyCell launches intelligence -powered monitoring to provide clarity to millions of drug shipments around the world
SkyCell has launched a drug monitoring offer with acting proceedings and smart devices. This new offer brings vision in actual time and risk management to Pharma Logistics, allowing companies full control over their operations.
Every year, one in five altogether is damaged in transit, due to late or incomplete monitoring. Traditional systems depend on eliminating data registration devices that only provide visions after birth, and are often very late to prevent loss. Feiled data and manual operations create blind spots that threaten the safety of the product and the safety of patients.
SkyCell Pharma Monitoring aims to face this challenge by providing a timer of temperature and location in an actual time without interruption. Using advanced predictive analyzes and a hybrid registrar that works as a registrar and gate, it eliminates blind spots and allows pre -emptive interventions.
To enhance the vision, SkyCell cooperated with Microsoft to integrate her auxiliary assistant AI, K.AI, directly into Microsoft and Copilot teams. This allows Pharma companies access to actual time charging data, receiving alerts, and cooperation through teams, all within the Microsoft ecosystem.
“The solution to our drug monitoring ensures that stakeholders no longer need to search for data schedules, emails or multiple platforms to stay in view and take decisions to save shipments early, by combining advanced analyzes with armed integration, surveillance of SkyCell, which work, and make sure of The changing medications of life reach patients safely and efficiently.
Post SkyCell launches intelligence -powered monitoring to provide a vision for millions of drug shipments around the world at the week of air cargo.
